遇见数据集

A Phase II study to evaluate the safety and potential palliative benefit of intraperitoneal bevacizumab in patients with symptomatic ascites due to advanced chemotherapy resistant gynaecological cancers: REZOLVE dataset

收藏
DataCite Commons2024-07-16 更新2025-04-17 收录
官方服务:

资源简介:

HeSANDA 1.0.0

提供机构:
University of Sydney
创建时间:
2024-07-16
二维码
社区交流群
二维码
科研交流群
商业服务